Subscribe to our press releases
Board member Poul Erik Schou-Pedersen leaves the board at his own request
ChromoGenics AB (publ) has accepted Poul Erik Schou-Pedersen’s request to leave the board. Poul Erik resigned from the Board on January 31, 2018.
Poul Erik Schou-Pedersen, representing New Energy Solutions II K / S – one of the company’s main owners, has announced to the Board of ChromoGenics AB that he wishes to resign as a member of the board due to that he enters an operational role as CEO of a Danish company and thus no longer has time.
The Board thanks Poul Erik for his great contribution and commitment to the company in the last decade, commented Anders Brännström, chairman of ChromoGenics AB.
Following the resignation of Poul Erik Schou-Pedersen, the Board consists of five members. Under the Articles of Association, the Board shall consist of three to seven members with a maximum of three deputy board members. The election of any alternate will take place at the next Annual General Meeting (AGM).
For more information, please contact
Thomas Almesjö, CEO
Susanne Andersson, CFO & Head of Communications
+46 (0)18 430 04 30
Certified Adviser: G&W Fondkommission
This information constitutes such information that ChromoGenics AB (publ) is obligated to disclose in accordance with the EU Market Abuse Regulation. The information was submitted by the above-mentioned contact persons for publication on 1 February 2018, at 08:30 p.m. CET.Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight® provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. ChromoGenics